Yahoo Web Search

  1. TNXP: Phase 3 Trial of TNX-102 SL in PTSD Underway…

    Zacks Small Cap Research via Yahoo FinanceApr 10 17:45 PM

    On March 11, 2019, Tonix Pharmaceuticals Holding Corp. (TNXP) announced the first patient has been enrolled in the RECOVERY Phase 3 study of TNX-102 SL in patients with posttraumatic stress ...